netrin-5 can initiate a cascade of signaling events within the cell that lead to the functional activation of this protein. Forskolin serves as one of these activators by targeting adenylate cyclase, thereby increasing the intracellular levels of cAMP. This rise in cAMP can, in turn, activate protein kinase A (PKA), which is known to phosphorylate various proteins, potentially including netrin-5, thereby promoting its activation. Likewise, IBMX functions by inhibiting phosphodiesterases, which prevents the breakdown of cAMP and thereby sustains the activity of PKA. This sustained activity can enhance the phosphorylation and subsequent activation of netrin-5. Additionally, Phorbol 12-myristate 13-acetate (PMA) is a potent activator of protein kinase C (PKC), and its activation can lead to the phosphorylation of target proteins, which may include netrin-5, culminating in the activation of netrin-5 signaling pathways.
Epidermal Growth Factor (EGF) binds to its receptor, triggering the MAPK/ERK pathway, a signaling route that can lead to the phosphorylation of various proteins including netrin-5, thus promoting its activation. Anisomycin, known for activating MAPK pathways, can also lead to the phosphorylation and activation of netrin-5. Ionomycin and A23187 both act to increase intracellular calcium levels, which can activate calcium-dependent kinases capable of phosphorylating and activating netrin-5. Phosphatidylserine is another molecule that can activate certain isoforms of PKC, potentially resulting in the activation of netrin-5 through phosphorylation. Dibutyryl-cAMP, a synthetic analog of cAMP, directly activates PKA, which then might phosphorylate and activate netrin-5. Bradykinin, through its action on the B2 receptor, can stimulate phospholipase C, leading to increased intracellular calcium, and this rise in calcium levels can activate netrin-5 via calcium-dependent signaling pathways. Each of these chemicals contributes to the regulatory network that can result in the activation of netrin-5 through distinct yet interconnected signaling pathways within the cell.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Inhibits phosphodiesterases, leading to increased cAMP levels that could enhance PKA activity to phosphorylate and activate netrin-5. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Acts as an activator of MAPK pathways which can lead to the activation of netrin-5 through downstream signaling effects. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium levels, which can activate calcium-dependent signaling pathways leading to the activation of netrin-5. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A calcium ionophore that raises intracellular calcium levels, potentially activating calcium-dependent kinases that activate netrin-5. | ||||||
L-α-Lecithin, Egg Yolk, Highly Purified | 8002-43-5 | sc-203096 | 250 mg | $135.00 | ||
Can activate protein kinase C isoforms which may result in phosphorylation and subsequent activation of netrin-5. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A cAMP analog that activates PKA, potentially leading to phosphorylation and activation of netrin-5. | ||||||
Bradykinin | 58-82-2 | sc-507311 | 5 mg | $110.00 | ||
Activates B2 receptor, leading to PLC activation, which can increase intracellular calcium and potentially activate netrin-5 via calcium signaling. | ||||||